PETCO HEALTH AND WELLNESS CO (WOOF)

US71601V1052 - Common Stock

4.6  +0.16 (+3.6%)

Fundamental Rating

1

WOOF gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 122 industry peers in the Specialty Retail industry. WOOF may be in some trouble as it scores bad on both profitability and health. WOOF does not seem to be growing, but still is valued expensively.



Quickly go to:

2

1. Profitability

1.1 Basic Checks

WOOF had negative earnings in the past year.
WOOF had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: WOOF reported negative net income in multiple years.
Each year in the past 5 years WOOF had a positive operating cash flow.

1.2 Ratios

With a Return On Assets value of -25.30%, WOOF is not doing good in the industry: 85.95% of the companies in the same industry are doing better.
WOOF has a Return On Equity of -117.99%. This is in the lower half of the industry: WOOF underperforms 77.69% of its industry peers.
Industry RankSector Rank
ROA -25.3%
ROE -117.99%
ROIC N/A
ROA(3y)-6.66%
ROA(5y)-4.39%
ROE(3y)-32.35%
ROE(5y)-23.03%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

WOOF's Operating Margin has declined in the last couple of years.
WOOF has a Gross Margin of 37.22%. This is comparable to the rest of the industry: WOOF outperforms 55.37% of its industry peers.
In the last couple of years the Gross Margin of WOOF has declined.
The Profit Margin and Operating Margin are not available for WOOF so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 37.22%
OM growth 3Y-43.66%
OM growth 5Y-27.59%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.21%
GM growth 5Y-2.8%

More info and screens

0

2. Health

2.1 Basic Checks

WOOF does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, WOOF has more shares outstanding
The number of shares outstanding for WOOF has been increased compared to 5 years ago.
The debt/assets ratio for WOOF is higher compared to a year ago.

2.2 Solvency

Based on the Altman-Z score of 1.03, we must say that WOOF is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 1.03, WOOF is not doing good in the industry: 71.90% of the companies in the same industry are doing better.
A Debt/Equity ratio of 1.39 is on the high side and indicates that WOOF has dependencies on debt financing.
WOOF has a Debt to Equity ratio of 1.39. This is in the lower half of the industry: WOOF underperforms 61.16% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.39
Debt/FCF N/A
Altman-Z 1.03
ROIC/WACCN/A
WACC10%

2.3 Liquidity

WOOF has a Current Ratio of 0.84. This is a bad value and indicates that WOOF is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.84, WOOF is doing worse than 85.12% of the companies in the same industry.
A Quick Ratio of 0.24 indicates that WOOF may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.24, WOOF is doing worse than 82.64% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.84
Quick Ratio 0.24

More info and screens

3

3. Growth

3.1 Past

The earnings per share for WOOF have decreased strongly by -120.00% in the last year.
WOOF shows a small growth in Revenue. In the last year, the Revenue has grown by 3.63%.
Measured over the past years, WOOF shows a small growth in Revenue. The Revenue has been growing by 7.33% on average per year.
EPS 1Y (TTM)-120%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%60%
Revenue 1Y (TTM)3.63%
Revenue growth 3Y8.33%
Revenue growth 5Y7.33%
Sales Q2Q%1.16%

3.2 Future

The Earnings Per Share is expected to grow by 39.73% on average over the next years. This is a very strong growth
WOOF is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.40% yearly.
EPS Next Y-171.77%
EPS Next 2Y-17.26%
EPS Next 3Y28.34%
EPS Next 5Y39.73%
Revenue Next Year-1.2%
Revenue Next 2Y0.64%
Revenue Next 3Y1.34%
Revenue Next 5Y1.4%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

WOOF reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
With a Price/Forward Earnings ratio of 74.67, WOOF can be considered very expensive at the moment.
Based on the Price/Forward Earnings ratio, WOOF is valued a bit more expensive than 62.81% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.38, WOOF is valued quite expensively.
Industry RankSector Rank
PE N/A
Fwd PE 74.67

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as WOOF.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 15.93

4.3 Compensation for Growth

A more expensive valuation may be justified as WOOF's earnings are expected to grow with 28.34% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-17.26%
EPS Next 3Y28.34%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for WOOF!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

PETCO HEALTH AND WELLNESS CO

NASDAQ:WOOF (12/18/2024, 1:28:44 PM)

4.6

+0.16 (+3.6%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap1.44B
Analysts
Price Target
Short Float %
Short Ratio
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 74.67
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -25.3%
ROE -117.99%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 37.22%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.18
Health
Industry RankSector Rank
Debt/Equity 1.39
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.84
Quick Ratio 0.24
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-120%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y-171.77%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)3.63%
Revenue growth 3Y8.33%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y